Examining the obstacles faced by female executives, and how organizations can increase female leadership and reap the benefits.
Our discussion with Ray Pisani, President & CEO of Alberta Blue Cross on leadership, motivation, and the value of diversity.
China’s pharmaceutical market offers vast opportunity for multinationals as regulatory and other changes shift the landscape.
Following some costly corporate compliance missteps at Novartis, Klaus Moosmayer will take over as Chief Ethics Officer.
Since taking the reins at GlaxoSmithKline, CEO Emma Walmsley has been reformulating the pharma giant’s executive team.
Jean-Baptiste Chasseloup de Chatillon, the CFO credited with a turnaround at PSA, takes his executive talent to French drug-maker Sanofi.
Japan’s Takeda Pharmaceutical has struck a £46bn ($62 billion) deal to acquire Irish rival Shire as part of its strategy to expand its global footprint.
Looking to streamline operations yet remain in the healthcare sector, GE has agreed to sell Veritas Capital a portion of its healthcare business.
A healthcare model from the combined forces of Amazon, JP Morgan and Berkshire Hathaway could catch on.